OTCPicks.com Stocks to Watch for Wednesday, November 28th MMGP, ISBL, CARN, PLKC, BMOD, STIY

Our Stocks to Watch tomorrow include MM2 Group, Inc. (OTCBB: MMGP), Ise Blu Equity Corp. (OTC: ISBL), Carrington Laboratories, Inc. (OTCBB: CARN), PlanetLink Communications Inc. (OTCBB: PLKC), Biomoda, Inc. (OTCBB: BMOD) and Stinger Systems, Inc. (OTCBB: STIY).

Visit http://www.otcpicks.com/ to register for our Daily Market Mover’s Digest Newsletter, and Email Stock Watch Alerts

MM2 GROUP, INC (OTCBB: MMGP)
"Up 222.58% on Tuesday"

Detailed Quote: http://www.otcpicks.com/quotes/MMGP.php

MM2 Group, Inc., through its subsidiary, Genotec Nutritionals, Inc., engages in the formulation, marketing, and distribution of nutritional supplements and vitamins in the United States. It sells various products, including fish oil, grape powder, resveratrol, lutein, and psyllium powder, as well as various custom formulations, such as formulations for diet, cardiac support, eye support, immunity support, and aging support. The company also sells custom formulations for pet care, including a shedding formula, a coat formula, dog and cat joint formulas, and pet multi-vitamins for dogs and cats. MM2 Group is based in Livingston, New Jersey.

MMGP News:

November 27 - MM2 Group Reports Record Net Income of $951,855 for Quarter Ending September 30, 2007

MM2 Group, Inc. (OTCBB: MMGP) reported on November 19, 2007, in a Form 10-QSB filing with the Securities and Exchange Commission, net income of $951,855 for the quarter ending September 30, 2007, which is the first quarter of fiscal 2008 for the Company. In the same time period last year, the Company reported a loss of $1,379,761.

Total sales for the three months ended September 30, 2007 and 2006 were $691,925 and $26,141, respectively. The increase in sales in 2007 was derived from the sales of nutritional supplements and vitamins by Genotec.

Total other (income) expense for the three months ended September 30, 2007 was an income of $1,236,773. This total was comprised of a gain on revaluation of derivatives of $1,563,953, consulting income of $70,000 and interest income of $5,050. These amounts are offset by amortization of the discount on debt conversion of $223,344, liquidated damages of $114,029, interest expense of $47,957 and beneficial interest expense of $16,900 due to the difference between value of the consulting fees and the fair value of the stock at the date of issuance. Loss from operations for the three months ended September 30, 2007 equaled $284,918 versus a loss of $202,182 in the same period last year.

This financial performance is a record in the history of the MM2 Group.

Mark Meller, CEO of MM2 Group, commented, "We are proud to report these results for the first quarter of 2008. The management team at Genotec Nutritionals, our wholly-owned subsidiary, is doing an excellent job of delivering great results."

Meller continued, "Business is excellent across the board. Our high potency fish oil soft gels continue to sell very well. Our cardiac care line, which is in beta testing at select outlets, shows very exciting potential. Our Sugarest(TM) diet product has captured the imagination of the news media throughout the United States, where it has been featured on over 100 television news programs on every major network in the country, and was even featured on ABC's national news program, Good Morning America. We look forward to continuing to deliver superior results throughout the rest of the year. Shareholders should read the complete details of our first quarter results in the Company's recently filed Form 10-QSB."

ISE BLU EQUITY CORPORATION (OTC: ISBL)
"Up 71.43% on Tuesday"

Detailed Quote: http://www.otcpicks.com/quotes/ISBL.php

Ise Blu Equity Corp. (http://www.isebluequitycorp.com/) is a Business Development Company of the Independent Film, Music, Live Events Licensing, Merchandising and New Media Broadcast Companies together, under one umbrella, to develop a strong and profitable revenue center that will bring quality product and services to customers worldwide.

ISBL News:

November 27 - Ise Blu Equity Corp. Subsidiary L.G.N. Entertainment Distribution Announces Distribution Agreements

Ise Blu Equity Corp. (OTC: ISBL) subsidiary L.G.N. Entertainment Distribution (http://www.lgnentertainment.com/), an independent distributor of Music, Videos, Movies and DVDs, announced that L.G.N and Select-O-Hits distribution will distribute the "Dog-On Television" DVD nationally to Wal-Mart store locations for the holidays. Wal-Mart selected only 12 DVD titles to be placed in their main aisles of their pet department and Dog-On Television couldn't have been a better choice.

"Dog-On Television will be a great Holiday gift for all canine lovers looking for a holiday gift for their pets. Select-O-Hits is extremely excited about this release and this will help set the foundation for future releases as we prepare for Nick Loren's CD release in 2008. Early projections are that we will ship upwards of 100,000 units for the holiday season," states Lisa Sam, President of L.G.N. Entertainment.

"Wal-Mart couldn't have chosen a better DVD to be sold in their store locations nationally. This will help drive revenues and profits with regard to L.G.N.'s holiday sales. This will also help with our future relationship with Walmart," stated Steve Lane, President of Ise Blu Equity Corp.

Dog-On Television was created by Nick and Denise Loren when they were faced with the very common problem of leaving their dog "Monty" home alone for hours on end. Nick and Denise both work in the entertainment industry, which sometimes calls them away for 14-hour days. "We were very surprised to find that aside from an occasional dog show on Animal Planet, there was nothing out there designed to entertain stay-at-home canines," says Nick Loren. Taking matters into their own hands, Nick and Denise set out to create a solution.

Pulling their "industry" resources, they began shooting footage at local dog parks. "Knowing that dogs react to other dogs, we knew that dog parks would be the best place to shoot. We were able to capture over 100 dogs interacting together in a natural environment. No gadgets, no gimmicks," Denise explains. Over 14 hours of footage was condensed down into the 60 minutes of the best footage (http://www.bowwowtv.com/).

"Monty loved it!" exclaims Nick. "He was mesmerized by the dogs on the TV. At first he was excited as he watched the dogs on the television. As days passed he became more relaxed and comforted by the dogs on the DVD." Excited by the results, Nick and Denise began sharing copies with their friends and family. The results were unanimous. When friends of friends began requesting DVDs, the couple decided to market the DVD to the general public. "Once we saw how much of a 'void' our DVD could fill, it was obvious that we needed to share it with other dog loving families that had the same concerns," says Nick. The couple called upon life long friend Jeeve, a successful music producer and film/video editor. The three put their creative forces and years of work experience together, and Bow Wow TV, Inc. was born.

CARRINGTON LABORATORIES (OTCBB: CARN)
"Up 55.00% on Tuesday"

Detailed Quote: http://www.otcpicks.com/quotes/CARN.php

Carrington Laboratories, Inc. is an ISO 9001-certified, research-based, biopharmaceutical and consumer products company currently utilizing naturally-occurring complex carbohydrates to manufacture and market products for mucositis, radiation dermatitis, wound and oral care, as well as to manufacture and market the nutraceutical raw material Manapol® and cosmetic raw material Hydrapol(TM). Carrington also manufactures and markets consumer products and manufactures quality products for other companies. Manufacturing operations comply with cGMP standards. Carrington's DelSite Biotechnologies subsidiary is developing its proprietary GelSite® technology which is designed to provide controlled release of peptide and protein-based drugs. Carrington's technology is protected by more than 130 patents in 26 countries. Select products carry the CE mark, recognized by more than 20 countries around the world. For more information, visit http://www.carringtonlabs.com/.

CARN News:

November 27 - Carrington Reports Third Quarter 2007 Results

Revenues Down from Same Quarter Last Year

Second Consecutive Double Digit Quarter-to-Quarter Revenue Gain

DelSite Continues Toward Phase I Vaccine Clinical Trial

Carrington Laboratories, Inc. (OTCBB: CARN) reported revenue for the quarter ended September 30, 2007 of $6.5 million, compared to $6.7 million in the year-ago period, as the Company discontinued certain unprofitable or marginally profitable products during the third quarter of the current year. However, the revenue in the quarter just ended, was 16 percent higher than the $5.6 million revenue reported for the second quarter of 2007, the second consecutive quarter-to-quarter revenue gain this year.

Medical Services revenue for the third quarter of 2007, at $1.9 million, was down from the year-ago level of $2.3 million. Consumer Services revenue grew 5 percent for the quarter, to $3.8 million from $3.6 million in the year-ago period. Grant income received for funding of research for the Company's wholly-owned drug delivery subsidiary, DelSite Biotechnologies, Inc., decreased by 4 percent for the quarter, to $776,000 from $811,000 a year ago.

Net loss for the third quarter of 2007, including $524,000 of net funding of DelSite, was $2.2 million, or 21 cents per basic and diluted share, an increase of $485,000 from the net loss reported for the year-ago quarter of $1.7 million, or 16 cents per basic and diluted share. Pro forma loss for the quarter, exclusive of DelSite net funding, was $1.7 million compared to a $1.1 million pro forma loss in the prior-year period.

"We continue on the road to bringing growth and profitability to our core business," said Carlton E. Turner, PhD, Carrington's CEO. "Our product revenue and margins improved again this quarter as we grew our more profitable product lines and reduced our overall operating costs."

Commenting on DelSite, Dr. Turner stated, "We continue to focus our strategy on building the clinical foundation of the GelSite® polymer drug delivery and adjuvant technologies and on moving them toward commercial introduction. We are seeing increasing interest from both commercial companies and government health agencies in our vaccine and therapeutic delivery systems for both nasal and injectible formulations. In addition, we continue on the path toward filing an IND and conducting a Phase I clinical study in early 2008 of the GelVac(TM) nasal powder influenza H5N1 (bird flu) vaccine."

PLANETLINK COMMUNICATIONS (OTCBB: PLKC)
"Up 58.33% on Tuesday"

Detailed Quote: http://www.otcpicks.com/quotes/PLKC.php

Planetlink Communications, Inc. (“PlanetLink” or the “Company”) was founded in 1999 and is based in Cumming, Georgia. The Company, through its subsidiaries, has been primarily in the business of developing satellite-enabled products based on global positioning systems (GPS) technology for vehicle tracking and fleet management. The company has had strategic alliances with WebTech Wireless, Inc., Karta Technologies, Inc., MapQuest.com, Inc., and Cingular Wireless, LLC. Planetlink is currently redefining its business focus through acquisitions of communications and media technology businesses with cutting-edge products and services for high growth markets. Recently, the Company acquired Pluginz, Inc., which operates the largest marketplace for third party software and has the largest catalog of creative software in the world. Pluginz is based in Palo Alto, California and operates a network of websites, http://www.pluginz.net/, that cater to the creative industries such as film, television and graphic design.

PLKC News:

November 27 - PlanetLink Completes Acquisition of DnC Multimedia

PlanetLink Communications Inc. (OTCBB: PLKC) announced that its subsidiary, Planettraks, Inc., has completed the acquisition of DnC Multimedia, Inc. As part of the deal, Chris Piercy, Robert Lott, Robert Lau, and Hanseo Park will join the PlanetLink Board of Directors. Also, Robert Lau has been appointed CFO of PlanetLink effective immediately. PlanetLink intends to change its name to "DnC Multimedia, Inc." in the near future.

Robert Lott, CEO of PlanetLink, commented, "I am very excited about the integration of DnC and Pluginz. We have always believed there is a strong synergy between the two companies, and now we finally have the opportunity to make a reality out of that vision. I am also looking forward to working with Robert Lau, as his many years of securities industry experience will be tremendously valuable to the Company."

BIOMODA INCORPORATED (OTCBB: BMOD)
"Up 47.06% on Tuesday"

Detailed Quote: http://www.otcpicks.com/quotes/BMOD.php

Biomoda, Inc., a development stage company, engages in the discovery, development, manufacture, and marketing of proprietary medical diagnostic and treatment products used to treat life threatening and other serious diseases. It focuses on creating diagnostic solutions for early detection and clinical management of cancer. The company's customers include reference clinical labs. It has collaboration with Tricore Reference Laboratories to conduct assay preparation, testing, and analysis of company's proprietary test for detection of early lung cancer as part of its clinical programs. Biomoda was founded in 1990 and is headquartered in Albuquerque, New Mexico.

BMOD News:

November 26 - Biomoda, Inc. Retains MicroCap Management, LLC as its Lead Corporate Communications and Broker Relations Firm.

Biomoda, Inc. (OTCBB: BMOD), maker of early-detection cancer diagnostic tests, has approved MicroCap Management as the front-runner of its full media campaign. MicroCap Management has created a strategic media plan that will provide a launch pad for present and future business driven by the progressive vision of Biomoda's Senior Executive Officers.

John Cousins, President of Biomoda announced, "MicroCap has the tools and connections to spread the word to the wider investment community about Biomoda and its potential." Alan Siegel, Managing Director of MicroCap Management, LLC stated: "We are thrilled to have Biomoda on board, and we're extremely enthusiastic about the future of this program."

MicroCap Management, LLC, headquartered in Orlando, Florida, is a Corporate Communications and Broker Relations firm that utilizes business-to-business marketing strategies and extensive relationships with major investment web portals to promote growth for publicly traded companies. Its Managing Directors possess 30+ years experience in marketing and advertising for OTC and Fortune 500 companies, and its highly trained Broker Relations staff has established relationships with broker/dealers nationwide, thereby providing maximum worldwide exposure to broker/dealers, investment bankers, wholesale and retail traders, as well as hedge fund managers and the global investment community.

MicroCap Management has its hands on the pulse of Wall Street, generating exposure and driving liquidity through its free Lead Generator Program and Broker Relations Campaigns; thereby creating a niche that traditional IR and PR firms haven't tapped.

MicroCap Management's core philosophy is to allow its corporate clients to focus on core business while managing its corporate communications and broker relations, and in doing so has frequently taken micro cap companies that were once acorns to a market penetration level of mature oak trees. As a side benefit, these strategies often assist in building the consumer markets as well, which in turn can contribute to increased shareholder equity.

Additionally, MicroCap Management's programs help companies meet pre-requisite criteria to qualify for listing on premier exchanges such as NASDAQ, AMEX and NYSE.

Biomoda's patented technology, a non-invasive cytology based assay, is designed for cancer screening of large populations at a reasonable cost. Current diagnostic methods for lung cancer, including CT scans and X-rays, often detect the disease only at more advanced stages and are relatively expensive.

STINGER SYSTEMS (OTCBB: STIY)
"Up 10.00% on Tuesday"

Detailed Quote: http://www.otcpicks.com/quotes/STIY.php

Stinger Systems, Inc. engages in manufacturing and marketing electronic restraint products to law enforcement, correctional, professional security, and military sectors. It produces and sells electronic stun devices for the control of, and to provide temporary incapacitation of, dangerous persons. The company markets S-200, a two-dart electronic projectile stun device, and TruVu camera, which offers the option of video and voice capture. The company's control products include Ice Shield, an electrified riot shield; Bandit, a remote controlled or movement controlled electrified wrap used for controlling dangerous detainees in public situations or during transport; and Ultron, a handheld contact stun device used to temporarily incapacitate dangerous individuals. The company was founded as United Consulting Corporation in 1996 and changed its name to Stinger Systems, Inc. in 2004. Stinger Systems, Inc. is based in Tampa, Florida.

STIY News:

November 27 - Stinger Systems Announces Orders for Over 100 Band-It(R) Prisoner Restraint Systems

Stinger Systems, Inc. (OTCBB: STIY), a leader in electro-stun technology, announced that orders for over 100 Band-It® prisoner restraint systems have been made. The Band-It® is a remotely activated stun cuff that is placed on a prisoner's leg or arm. If an individual flees, a law enforcement official can remotely activate the cuff to stun the prisoner to help prevent them from fleeing or committing a violent action.

Robert Gruder, Stinger Systems' Chief Executive Officer, stated, "Stinger Systems appears to be in a good growth mode. We hired several new sales personnel in October and their efforts look positive right now. We have world class electro-stun technology and now the law enforcement community is beginning to take notice."

ABOUT OTCPICKS.COM

OTCPicks.com is an Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Profile Research Reports authored by our financial writers. We publish a daily Newsletter to subscribers, and we publish our Daily Market Movers Digest which is sent out on the M2 Presswire several times daily highlighting hot OTC and OTCBB stocks. To feature a company on our web site or in our daily Newsletter or Market Mover’s Digest, please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com.

Disclaimer:
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. This disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE: The OTCPicks.com employees are NOT Registered as an Investment Advisor in any jurisdiction whatsoever.

Release of Liability:
Through use of this website viewing or using you agree to hold OTCPicks.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a representation by the publisher nor a solicitation of the purchase or sale of any securities. OTCPicks.com has been compensated ten thousand free trading shares by a non-controlling third party (OTC Investor Source) for BMOD advertising and promotional services. For a complete list of disclosures go to http://www.otcpicks.com/disclosure_details.php. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. OTCPicks.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and OTCPicks.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. OTCPicks.com and its affiliates are not registered investment advisors or a broker dealers. OTCPicks.com has been advised that the investments in companies profiled are considered to be high risk and use of the information provided is at the investor’s sole risk. OTCPicks.com also advises that the purchase of such high risk securities may result in the loss of some or all of the investment. Investors should not rely solely on the information presented. Rather, investors should use the information provided by the profiled companies as a starting point for doing additional independent research on the profiled companies in order to allow the investor to form his or her own opinion regarding investing in the profiled companies. Factual statements made by the profiled companies are made as of the date stated and are subject to change without notice. Investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. OTCPicks.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through OTCPicks.com. OTCPicks.com owners may or may not hold positions in the companies that are profiled.

The information contained herein contains forward-looking information within the meaning of Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 including statements regarding expected continual growth of the company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect the company's actual results of operation. Factors that could cause actual results to differ include the size and growth of the market for the company's products, the company's ability to fund its capital requirements in the near term and in the long term, pricing pressures, unforeseen and/or unexpected circumstances in happenings, pricing pressures, etc. Investing in securities is speculative and carries risk. Past performance does not guarantee future results.

Third Party Web Sites and Information:

OTCPicks.com and newsletter may provide hyperlinks to third party websites or access to third party content. OTCPicks.com does not control, endorse, or guarantee content found in such sites. You agree that OTCPicks.com is not responsible for any content, associated links, resources, or services associated with a third party site. You further agree that OTCPicks.com shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only.